227 related articles for article (PubMed ID: 27090377)
1. Development of a Luminex-Based DIVA Assay for Serological Detection of African Horse Sickness Virus in Horses.
Sánchez-Matamoros A; Nieto-Pelegrín E; Beck C; Rivera-Arroyo B; Lecollinet S; Sailleau C; Zientara S; Sánchez-Vizcaíno JM
Transbound Emerg Dis; 2016 Aug; 63(4):353-9. PubMed ID: 27090377
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
[TBL] [Abstract][Full Text] [Related]
3. Development of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.
Sánchez-Matamoros A; Beck C; Kukielka D; Lecollinet S; Blaise-Boisseau S; Garnier A; Rueda P; Zientara S; Sánchez-Vizcaíno JM
Transbound Emerg Dis; 2016 Dec; 63(6):e270-e277. PubMed ID: 25693720
[TBL] [Abstract][Full Text] [Related]
4. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a new lateral flow assay for simultaneous detection of antibodies against African Horse Sickness and Equine Infectious Anemia viruses.
Costa S; Sastre P; Pérez T; Tapia I; Barrandeguy M; Sánchez-Vizcaíno JM; Sánchez-Matamoros A; Wigdorovitz A; Sanz A; Rueda P
J Virol Methods; 2016 Nov; 237():127-131. PubMed ID: 27616197
[TBL] [Abstract][Full Text] [Related]
6. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
[TBL] [Abstract][Full Text] [Related]
7. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
8. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
9. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibodies binding to the VP7 protein of African horse sickness virus.
Luciani M; Armillotta G; Ciarelli A; Ulisse S; Teodori L; Bortone G; Giamboi A; Monaco F; Tittarelli M; Di Ventura M; Iannetti L; Podaliri Vulpiani M; Di Febo T
J Virol Methods; 2019 Aug; 270():131-136. PubMed ID: 31095974
[TBL] [Abstract][Full Text] [Related]
13. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1.
Wang Y; Ong J; Ng OW; Songkasupa T; Koh EY; Wong JPS; Puangjinda K; Fernandez CJ; Huangfu T; Ng LC; Chang SF; Yap HH
Emerg Infect Dis; 2022 Dec; 28(12):2446-2454. PubMed ID: 36417933
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
Weyer CT; Grewar JD; Burger P; Joone C; Lourens C; MacLachlan NJ; Guthrie AJ
Vaccine; 2017 Apr; 35(18):2504-2510. PubMed ID: 28341113
[TBL] [Abstract][Full Text] [Related]
15. Western immunoblotting as a method for the detection of African horse sickness virus protein-specific antibodies: differentiation between infected and vaccinated horses.
Bougrine SI; Fihri OF; Fehri MM
Arch Virol Suppl; 1998; 14():329-36. PubMed ID: 9785518
[TBL] [Abstract][Full Text] [Related]
16. The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses.
Laviada MD; Roy P; Sánchez-Vizcaíno JM; Casal JI
Virus Res; 1995 Oct; 38(2-3):205-18. PubMed ID: 8578859
[TBL] [Abstract][Full Text] [Related]
17. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
[TBL] [Abstract][Full Text] [Related]
18. Immune response of horses to inactivated African horse sickness vaccines.
Rodríguez M; Joseph S; Pfeffer M; Raghavan R; Wernery U
BMC Vet Res; 2020 Sep; 16(1):322. PubMed ID: 32873300
[TBL] [Abstract][Full Text] [Related]
19. Development of competitive ELISA for serodiagnosis on African horsesickness virus using baculovirus expressed VP7 and monoclonal antibody.
Kweon CH; Kwon BJ; Ko YJ; Kenichi S
J Virol Methods; 2003 Oct; 113(1):13-8. PubMed ID: 14500122
[TBL] [Abstract][Full Text] [Related]
20. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
